|
The purpose of this Confidential Investment Offering Overview is to provide a summary of a possible future private investment opportunity that may be made available to a certain limited number of accredited investors. This is not an offer to sell real estate and/or any type of security, partnership interest, public or otherwise.
 |
14 years remaining on a non-cancellable net lease. |
|
Fresenius is the world’s largest integrated provider of products and services for patients with kidney failure. . |
|
Over 2,599 facilities worldwide and providing treatment to 202,414 patients around the globe. |
|
Fresenius Medical Care AG & Co has annual revenues in excess of $11 billion with net income of $891 million. |
|
|
The contemplated offering, if made available formally, would provide investors with the opportunity to acquire a partial interest in a newly built 9,160 square foot medical care facility located in Gary (Greater Chicago), Indiana. The building is 100% double net leased to Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGAA, the world's largest integrated provider of products and services for individuals undergoing dialysis due to chronic kidney failure. Fresenius Medical Care’s more than 25 years of experience in this industry, makes them a world leader in dialysis products and services.
The property is being acquired for $2,029,000 with all equity financing, eliminating mortgage debt and risk with a 14 year, non-cancellable net lease.
 Fresenius Medical Care North America ("FMCNA") is a major provider of kidney dialysis services and renal care products in the US. They provide dialysis products and equipment, dialysis care services, and education and support for Chronic Kidney Disease, including treatment options for later stage kidney disease. Their dialysis care services include hemodialysis, peritoneal dialysis, renal pharmaceuticals, and transplant support services. Fresenius Medical Care manufactures and distributes a variety of dialysis products and equipment, including dialysis machines, supplies for both home and clinic-based dialysis treatments, and educational toolkits.
FMCNA employs approximately 39,000 people nationwide who share in a commitment to deliver the highest quality of services for their patients and health care partners. Through Fresenius Medical Services, their dialysis services entity, FMCNA provides ongoing dialysis treatment for more than 128,700 patients through their network of over 1,700 facilities nationwide making FMCNA the largest provider of renal services in North America.
 Fresenius Medical Care AG & Co KGAA generated approximately $11.2 billion in revenues for the year ending December 31, 2009, with a net income of $891 million, and shareholder's equity over $6.8 billion. Additionally, in the first 6 months of 2010 Fresenius Medical Care AG & Co. had revenues of $5.8 billion with a net income of $459 million. Fresenius Medical Care AG & Co. is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P). More information regarding Fresenius Medical Care may be found by visiting www.fmcna.com.
|
